Your browser doesn't support javascript.
Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic.
Siskind, Dan; Northwood, Korinne; Berk, Michael; Castle, David; Galletly, Cherrie; Harris, Anthony.
  • Siskind D; Princess Alexandra Hospital, Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia.
  • Northwood K; School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Berk M; Princess Alexandra Hospital, Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia.
  • Castle D; School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Galletly C; Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.
  • Harris A; IMPACT Strategic Research Centre, Barwon Health, Deakin University, Geelong, VIC, Australia.
Aust N Z J Psychiatry ; 54(7): 759-761, 2020 Jul.
Article in English | MEDLINE | ID: covidwho-260184
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Conscious Sedation / Drug Monitoring / Coronavirus Infections / Delirium / Olanzapine Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Oceania Language: English Journal: Aust N Z J Psychiatry Year: 2020 Document Type: Article Affiliation country: 0004867420927465

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Conscious Sedation / Drug Monitoring / Coronavirus Infections / Delirium / Olanzapine Type of study: Observational study Topics: Long Covid Limits: Humans Country/Region as subject: Oceania Language: English Journal: Aust N Z J Psychiatry Year: 2020 Document Type: Article Affiliation country: 0004867420927465